Community-based opioid overdose prevention programs providing naloxone - United States, 2010
- PMID: 22337174
- PMCID: PMC4378715
Community-based opioid overdose prevention programs providing naloxone - United States, 2010
Abstract
Drug overdose death rates have increased steadily in the United States since 1979. In 2008, a total of 36,450 drug overdose deaths (i.e., unintentional, intentional [suicide or homicide], or undetermined intent) were reported, with prescription opioid analgesics (e.g., oxycodone, hydrocodone, and methadone), cocaine, and heroin the drugs most commonly involved . Since the mid-1990s, community-based programs have offered opioid overdose prevention services to persons who use drugs, their families and friends, and service providers. Since 1996, an increasing number of these programs have provided the opioid antagonist naloxone hydrochloride, the treatment of choice to reverse the potentially fatal respiratory depression caused by overdose of heroin and other opioids. Naloxone has no effect on non-opioid overdoses (e.g., cocaine, benzodiazepines, or alcohol) . In October 2010, the Harm Reduction Coalition, a national advocacy and capacity-building organization, surveyed 50 programs known to distribute naloxone in the United States, to collect data on local program locations, naloxone distribution, and overdose reversals. This report summarizes the findings for the 48 programs that completed the survey and the 188 local programs represented by the responses. Since the first opioid overdose prevention program began distributing naloxone in 1996, the respondent programs reported training and distributing naloxone to 53,032 persons and receiving reports of 10,171 overdose reversals. Providing opioid overdose education and naloxone to persons who use drugs and to persons who might be present at an opioid overdose can help reduce opioid overdose mortality, a rapidly growing public health concern.
Figures


Similar articles
-
Opioid Overdose Prevention Programs Providing Naloxone to Laypersons - United States, 2014.MMWR Morb Mortal Wkly Rep. 2015 Jun 19;64(23):631-5. MMWR Morb Mortal Wkly Rep. 2015. PMID: 26086633 Free PMC article.
-
Opioid education and nasal naloxone rescue kits in the emergency department.West J Emerg Med. 2015 May;16(3):381-4. doi: 10.5811/westjem.2015.2.24909. Epub 2015 Apr 1. West J Emerg Med. 2015. PMID: 25987910 Free PMC article.
-
HIV prevention and treatment strategies can help address the overdose crisis.Prev Med. 2015 Nov;80:37-40. doi: 10.1016/j.ypmed.2015.04.004. Epub 2015 Apr 18. Prev Med. 2015. PMID: 25895840
-
A Review of Opioid Overdose Prevention and Naloxone Prescribing: Implications for Translating Community Programming Into Clinical Practice.Subst Abus. 2015;36(2):240-53. doi: 10.1080/08897077.2015.1010032. Epub 2015 Mar 16. Subst Abus. 2015. PMID: 25774771 Free PMC article. Review.
-
The Opioid Crisis and the Physician's Role in Contributing to its Resolution: Step One--Prevention of Overdoses.Conn Med. 2016 Jun-Jul;80(6):325-34. Conn Med. 2016. PMID: 27509638 Review.
Cited by
-
Assessment of the safety and ease of use of the naloxone auto-injector for the reversal of opioid overdose.Open Access Emerg Med. 2015 Jun 8;7:21-4. doi: 10.2147/OAEM.S82133. eCollection 2015. Open Access Emerg Med. 2015. PMID: 27147886 Free PMC article. Review.
-
Orienting patients to greater opioid safety: models of community pharmacy-based naloxone.Harm Reduct J. 2015 Aug 6;12:25. doi: 10.1186/s12954-015-0058-x. Harm Reduct J. 2015. PMID: 26245865 Free PMC article.
-
Development of a Risk Index for Serious Prescription Opioid-Induced Respiratory Depression or Overdose in Veterans' Health Administration Patients.Pain Med. 2015 Aug;16(8):1566-79. doi: 10.1111/pme.12777. Epub 2015 Jun 5. Pain Med. 2015. PMID: 26077738 Free PMC article.
-
Utilizing social media to explore overdose and HIV/HCV risk behaviors among current opioid misusers.Drug Alcohol Depend. 2019 Dec 1;205:107690. doi: 10.1016/j.drugalcdep.2019.107690. Epub 2019 Oct 28. Drug Alcohol Depend. 2019. PMID: 31778902 Free PMC article.
-
A Dissemination and Implementation Science Approach to the Epidemic of Opioid Use Disorder in the United States.Curr HIV/AIDS Rep. 2018 Oct;15(5):359-370. doi: 10.1007/s11904-018-0409-9. Curr HIV/AIDS Rep. 2018. PMID: 30069724 Free PMC article. Review.
References
-
- CDC. WONDER [Database] Atlanta, GA: US Department of Health and Human Services, CDC; 2012. [Accessed February 13, 2012]. Available at http://wonder.cdc.gov.
-
- Hardman JG, Limbird LE, editors. Goodman and Gilman’s the pharmacologic basis of therapeutics. 11. New York, NY: McGraw-Hill; 2006. pp. 576–8.
-
- Wermeling DP. Opioid harm reduction strategies: focus on expanded access to intranasal naloxone [Editorial] Pharmacotherapy. 2010;30:627–31. - PubMed
-
- Lagu T, Anderson BJ, Stein M. Overdoses among friends: drug users are willing to administer naloxone to others. J Subst Abuse Treat. 2006;30:129–33. - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical